Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Northwest Biotech Corp. was a biotechnology and pharmaceutical company that specialized in the development, manufacture, and distribution of all-natural herbal medicines and traditional Chinese medicine (TCM) products. Originally incorporated as AVL Global, Inc. in 2004, the company adopted the China Northwest Biotech name in 2006 to focus on the growing natural health market in China. The company operated primarily through its subsidiaries in China, producing a range of herbal-based treatments for various health conditions. It was publicly traded on the US OTC market under the ticker symbol CNWB. In 2007, the company underwent a series of name changes and eventually transitioned its business focus away from the life sciences sector, ultimately becoming Seeker Tec International.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Northwest Biotech.